Conmed (NASDAQ: CNMD) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $193.4 million versus the consensus estimate of $191.48 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.